LLY - Lilly(Eli) & Co
Close
960.02
19.820 2.065%
Share volume: 2,549,154
Last Updated: Fri 30 Aug 2024 10:02:17 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$940.20
19.82
2.11%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-01 | 2023-02-22 | 2023-04-27 | 2023-08-08 | 2023-11-02 | 2024-02-21 | 2024-04-30 | |
| Assets | |||||||||
| Total Assets | 47.064 B | 47.462 B | 49.490 B | 53.163 B | 54.814 B | 57.916 B | 64.006 B | 63.944 B | |
| Current Assets | 17.115 B | 17.640 B | 18.035 B | 20.811 B | 21.332 B | 23.007 B | 25.727 B | 25.189 B | |
| Inventories | 3.899 B | 3.831 B | 4.310 B | 4.545 B | 4.799 B | 4.901 B | 5.773 B | 6.102 B | |
| Other Current Assets | 2.807 B | 2.742 B | 2.954 B | 3.575 B | 4.532 B | 5.248 B | 5.690 B | 6.487 B | |
| Short Term Investments | 2.807 B | 2.742 B | 2.954 B | 3.575 B | 4.532 B | 5.248 B | 5.690 B | 6.487 B | |
| Total Receivables | 7.672 B | 8.325 B | 8.559 B | 9.022 B | 9.171 B | 10.364 B | 11.336 B | 10.014 B | |
| Current Cash | 2.737 B | 2.742 B | 2.212 B | 3.669 B | 2.829 B | 2.494 B | 2.928 B | 2.586 B | |
| Total Non-current Assets | 29.948 B | 29.822 B | 31.455 B | 32.352 B | 33.482 B | 34.909 B | 38.279 B | 38.755 B | |
| Property Plant Equipment | 9.128 B | 9.311 B | 10.144 B | 10.546 B | 11.277 B | 11.863 B | 12.914 B | 13.624 B | |
| Other Assets | 4.472 B | 4.536 B | 4.337 B | 4.488 B | 4.672 B | 4.912 B | 4.990 B | 4.708 B | |
| Intangible Assets | 7.498 B | 7.124 B | 7.207 B | 7.087 B | 6.904 B | 6.782 B | 6.907 B | 6.762 B | |
| Goodwill | 3.892 B | 3.892 B | 4.073 B | 4.073 B | 4.079 B | 4.085 B | 4.940 B | 4.940 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 47.064 B | 47.462 B | 49.490 B | 53.163 B | 54.814 B | 57.916 B | 64.006 B | 63.944 B | |
| Total liabilities | 38.519 B | 37.391 B | 38.840 B | 41.973 B | 43.750 B | 46.695 B | 53.234 B | 51.131 B | |
| Total current liabilities | 15.621 B | 15.653 B | 17.138 B | 16.010 B | 18.915 B | 21.998 B | 27.293 B | 18.598 B | |
| Accounts Payable | 1.659 B | 1.683 B | 1.931 B | 2.016 B | 2.474 B | 2.435 B | 2.599 B | 2.474 B | |
| Other liabilities | 7.229 B | 7.327 B | 6.751 B | 6.978 B | 6.591 B | 6.686 B | 7.529 B | 7.888 B | |
| Current long term debt | 2.122 B | 1.745 B | 1.501 B | 3.100 M | 661.600 M | 2.245 B | 6.905 B | 1.652 B | |
| Long term debt | 14.692 B | 14.144 B | 14.738 B | 18.881 B | 18.158 B | 17.924 B | 18.321 B | 24.560 B | |
| Other liabilities | 7.229 B | 7.327 B | 6.751 B | 6.978 B | 6.591 B | 6.686 B | 7.529 B | 7.888 B | |
| Minority interest | 114.500 M | 95.800 M | 125.600 M | 104.500 M | 85.500 M | 87.000 M | 91.800 M | 85.200 M | |
| Total Shareholder equity | 8.545 B | 10.070 B | 10.650 B | 11.190 B | 11.064 B | 11.220 B | 10.772 B | 12.812 B | |
| Common stock | 900.300 M | 900.700 M | 902.244 M | 901.000 M | 899.700 M | 899.800 M | 900.224 M | 900.800 M | |
| Retained earnings | 8.556 B | 10.007 B | 10.043 B | 10.639 B | 10.369 B | 10.310 B | 10.312 B | 12.554 B |